JPS6256851B2 - - Google Patents
Info
- Publication number
- JPS6256851B2 JPS6256851B2 JP54069545A JP6954579A JPS6256851B2 JP S6256851 B2 JPS6256851 B2 JP S6256851B2 JP 54069545 A JP54069545 A JP 54069545A JP 6954579 A JP6954579 A JP 6954579A JP S6256851 B2 JPS6256851 B2 JP S6256851B2
- Authority
- JP
- Japan
- Prior art keywords
- chloro
- naphthoquinone
- compound represented
- formula
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000124008 Mammalia Species 0.000 claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 25
- 229930192627 Naphthoquinone Natural products 0.000 claims description 15
- 150000002791 naphthoquinones Chemical class 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 claims description 6
- ZJPOEIQBAPCMMA-UHFFFAOYSA-N ClC1=CC=C2C(=O)C(O)=CC(=O)C2=C1 Chemical compound ClC1=CC=C2C(=O)C(O)=CC(=O)C2=C1 ZJPOEIQBAPCMMA-UHFFFAOYSA-N 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 229940015043 glyoxal Drugs 0.000 claims description 3
- 229940030999 antipsoriatics Drugs 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 206010065874 Psoriatic conditions Diseases 0.000 claims 1
- 238000009835 boiling Methods 0.000 claims 1
- 239000012429 reaction media Substances 0.000 claims 1
- QLHIGRZXEPMGMR-UHFFFAOYSA-N 6-chloro-2,3-dihydroxynaphthalene-1,4-dione Chemical compound ClC1=CC=C2C(=O)C(O)=C(O)C(=O)C2=C1 QLHIGRZXEPMGMR-UHFFFAOYSA-N 0.000 abstract description 8
- 230000002682 anti-psoriatic effect Effects 0.000 abstract description 8
- 239000002904 solvent Substances 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 11
- 239000002585 base Substances 0.000 description 10
- 210000001339 epidermal cell Anatomy 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- -1 1,2-propylene diol Chemical class 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 6
- 230000004663 cell proliferation Effects 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 6
- 229940104230 thymidine Drugs 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229940125782 compound 2 Drugs 0.000 description 5
- 239000008194 pharmaceutical composition Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 229910052722 tritium Inorganic materials 0.000 description 5
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- 201000004681 Psoriasis Diseases 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 230000006820 DNA synthesis Effects 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical group CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 150000002191 fatty alcohols Chemical class 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000003883 ointment base Substances 0.000 description 3
- 235000019271 petrolatum Nutrition 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000003871 white petrolatum Substances 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 239000002178 crystalline material Substances 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- CSFWPUWCSPOLJW-UHFFFAOYSA-N lawsone Chemical compound C1=CC=C2C(=O)C(O)=CC(=O)C2=C1 CSFWPUWCSPOLJW-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 2
- 229940071536 silver acetate Drugs 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- FRASJONUBLZVQX-UHFFFAOYSA-N 1,4-naphthoquinone Chemical compound C1=CC=C2C(=O)C=CC(=O)C2=C1 FRASJONUBLZVQX-UHFFFAOYSA-N 0.000 description 1
- VSNHCAURESNICA-NJFSPNSNSA-N 1-oxidanylurea Chemical compound N[14C](=O)NO VSNHCAURESNICA-NJFSPNSNSA-N 0.000 description 1
- CCTJHVLTAJTPBV-UHFFFAOYSA-N 2-chloro-1,4-naphthoquinone Chemical compound C1=CC=C2C(=O)C(Cl)=CC(=O)C2=C1 CCTJHVLTAJTPBV-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- SHZFUTHHQBTADS-UHFFFAOYSA-N 6-bromo-2,3-dihydroxynaphthalene-1,4-dione Chemical compound BrC1=CC=C2C(=O)C(O)=C(O)C(=O)C2=C1 SHZFUTHHQBTADS-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- BEQQYEMVEPYBQK-UHFFFAOYSA-N C1=C(Cl)C=C2C(=O)C(O)=CC(=O)C2=C1 Chemical compound C1=C(Cl)C=C2C(=O)C(O)=CC(=O)C2=C1 BEQQYEMVEPYBQK-UHFFFAOYSA-N 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 239000006144 Dulbeccoâs modiï¬ed Eagle's medium Substances 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- XGEJPZWLVJMNCR-UHFFFAOYSA-N OC(O)=O.Cl.Cl.Cl.Cl Chemical compound OC(O)=O.Cl.Cl.Cl.Cl XGEJPZWLVJMNCR-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 238000011461 current therapy Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- BXUKAXFDABMVND-UHFFFAOYSA-L disodium;1,2-dihydroxyethane-1,2-disulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C(O)C(O)S([O-])(=O)=O BXUKAXFDABMVND-UHFFFAOYSA-L 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- PKHMTIRCAFTBDS-UHFFFAOYSA-N hexanoyl hexanoate Chemical compound CCCCCC(=O)OC(=O)CCCCC PKHMTIRCAFTBDS-UHFFFAOYSA-N 0.000 description 1
- 229940125697 hormonal agent Drugs 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
- 229960004961 mechlorethamine Drugs 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000003345 scintillation counting Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940100615 topical ointment Drugs 0.000 description 1
- BYGOPQKDHGXNCD-UHFFFAOYSA-N tripotassium;iron(3+);hexacyanide Chemical compound [K+].[K+].[K+].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] BYGOPQKDHGXNCD-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/32—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
- C07C17/10—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
- C07C17/14—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms in the side-chain of aromatic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/54—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C46/00—Preparation of quinones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
ãã®çºæã¯ãæ°èŠãªãããããã³é¡ããããã®
補æ³äžŠã³ã«åºä¹³åç©ã®ä¹Ÿç¬ã®æ²»çã®çºã®ãããã®
䜿çšã«é¢ããã
補æ³äžŠã³ã«åºä¹³åç©ã®ä¹Ÿç¬ã®æ²»çã®çºã®ãããã®
䜿çšã«é¢ããã
也ç¬ã¯ãéšåçã«ã¯ãè¡šç®çŽ°èã®éå°å¢æ®ã«ã
ã€ãŠç¹åŸŽã¥ããããç®èç ã§ãã€ãŠããã®ä»£è¡šç
çç¶ãšããŠãè¡šç®ã匷ãç²çããçµéããŠé±çäœ
ãšãªããçŸåšçšããããŠããçæ³ã«æ²»ççæ¹æ³ãš
ã¯èšãããã³ã«ãã³ã¹ããã€ãã®ãããªãã«ã¢ã³
å€ã䜿çšãããããŸãã¯ããããã·å°¿çŽ ãã¡ãœã
ã¬ãã»ãŒãåã³ãã€ãããžãšã³ã»ãã¹ã¿ãŒãã®ã
ããªçã®ååŠçæ³ã«é¢ããååç©ã䜿çšããããš
ã«ãã€ãŠè¡šç®çŽ°èå¢æ®ãæå¶ãããã®ã§ããã
ã€ãŠç¹åŸŽã¥ããããç®èç ã§ãã€ãŠããã®ä»£è¡šç
çç¶ãšããŠãè¡šç®ã匷ãç²çããçµéããŠé±çäœ
ãšãªããçŸåšçšããããŠããçæ³ã«æ²»ççæ¹æ³ãš
ã¯èšãããã³ã«ãã³ã¹ããã€ãã®ãããªãã«ã¢ã³
å€ã䜿çšãããããŸãã¯ããããã·å°¿çŽ ãã¡ãœã
ã¬ãã»ãŒãåã³ãã€ãããžãšã³ã»ãã¹ã¿ãŒãã®ã
ããªçã®ååŠçæ³ã«é¢ããååç©ã䜿çšããããš
ã«ãã€ãŠè¡šç®çŽ°èå¢æ®ãæå¶ãããã®ã§ããã
äžè¿°ã®è¬å€ã¯ããçšåºŠæå¹ã§ããããå±æçã«
ãããŸãå šèº«ç³»ã«ãå€ãã®é倧ãªå¥œãŸããããã
å¯äœçšãçããã
ãããŸãå šèº«ç³»ã«ãå€ãã®é倧ãªå¥œãŸããããã
å¯äœçšãçããã
æ¬çºæã®ååç©ãšååŠçã«é¢é£ããããçš®ã®ã
ããããã³é¡ã¯æ¢ç¥ã§ãããããšãã°ãïŒâãã
ã¢âïŒã»ïŒâãžããããã·âïŒã»ïŒâããããã
ã³ããŠãšã€ã¬ã³ãã®ãã€ãç¹èš±859008ã«å ±åãã
ãŠããããã®ååç©ã¯ææ補é ã«æŒããæçšãªäž
éäœã§ãããšèªããããŠããããæçšãªçç©åŠç
掻æ§ã«ã€ããŠã¯ãããŸã§çºè¡šãããªãã€ããç¹
ã«ããã®ååç©ãæ也ç¬æŽ»æ§ã瀺ããããããªã
ãšãããããªã瀺åããããŸã§æ瀺ãããªãã€
ãã
ããããã³é¡ã¯æ¢ç¥ã§ãããããšãã°ãïŒâãã
ã¢âïŒã»ïŒâãžããããã·âïŒã»ïŒâããããã
ã³ããŠãšã€ã¬ã³ãã®ãã€ãç¹èš±859008ã«å ±åãã
ãŠããããã®ååç©ã¯ææ補é ã«æŒããæçšãªäž
éäœã§ãããšèªããããŠããããæçšãªçç©åŠç
掻æ§ã«ã€ããŠã¯ãããŸã§çºè¡šãããªãã€ããç¹
ã«ããã®ååç©ãæ也ç¬æŽ»æ§ã瀺ããããããªã
ãšãããããªã瀺åããããŸã§æ瀺ãããªãã€
ãã
æçè掻æ§åã³æè掻æ§ã瀺ãé¢é£ããããã
ã³é¡ã¯ç±³åœç¹èš±3914264䞊ã³ã«è¥¿ãã€ãå ¬éç¹èš±
åºé¡2135712ã2456655åã³2520739ã«èšèŒãããŠ
ãããããããªããããããã®ç¹èš±ã¯ããããã
ãããã®ãŸãã¯é¢é£ãããããããã³çµæç©ãæ
也ç¬å€ãšããŠçšããããšã«ã€ããŠå šãèšèŒãããŠ
ããªãã
ã³é¡ã¯ç±³åœç¹èš±3914264䞊ã³ã«è¥¿ãã€ãå ¬éç¹èš±
åºé¡2135712ã2456655åã³2520739ã«èšèŒãããŠ
ãããããããªããããããã®ç¹èš±ã¯ããããã
ãããã®ãŸãã¯é¢é£ãããããããã³çµæç©ãæ
也ç¬å€ãšããŠçšããããšã«ã€ããŠå šãèšèŒãããŠ
ããªãã
ããçš®ã®é¢é£ååç©ãäŸãã°ãïŒâã¯ããâïŒ
âããããã·âïŒã»ïŒâãããããã³ãïŒâã¯ã
ãâïŒâããããã·âïŒã»ïŒâãããããã³åã³
ïŒâã¯ããâïŒã»ïŒã»ïŒâããªã¢ã»ããã·ããã
ããã³ãæãã©ãªã¢æŽ»æ§ã瀺ãããšãæ瀺ãããŠ
ãããL.F.Fieseråã³R.H.BrownãJ.Am.Chem.
Soc.71ã3615â17ïŒ1949ïŒãåç §ããããã
âããããã·âïŒã»ïŒâãããããã³ãïŒâã¯ã
ãâïŒâããããã·âïŒã»ïŒâãããããã³åã³
ïŒâã¯ããâïŒã»ïŒã»ïŒâããªã¢ã»ããã·ããã
ããã³ãæãã©ãªã¢æŽ»æ§ã瀺ãããšãæ瀺ãããŠ
ãããL.F.Fieseråã³R.H.BrownãJ.Am.Chem.
Soc.71ã3615â17ïŒ1949ïŒãåç §ããããã
ä»ãæ°èŠååç©ïŒâã¯ããâïŒã»ïŒâãžããã
ãã·âïŒã»ïŒâãããããã³åã³ãã®ïŒã»ïŒâãž
ãšã¹ãã«é¡ã¯ãåºä¹³åç©ã«å±æé©çšããæãè¡šç®
现èã®å¢æ®ãé»æ¢ããã®ã«æå¹ã§ããããšãèŠåº
ãããç¹ã«ããããã®ååç©ã¯ããã«å¯Ÿãæ也ç¬
å€ãšããŠæå¹ã§ããã
ãã·âïŒã»ïŒâãããããã³åã³ãã®ïŒã»ïŒâãž
ãšã¹ãã«é¡ã¯ãåºä¹³åç©ã«å±æé©çšããæãè¡šç®
现èã®å¢æ®ãé»æ¢ããã®ã«æå¹ã§ããããšãèŠåº
ãããç¹ã«ããããã®ååç©ã¯ããã«å¯Ÿãæ也ç¬
å€ãšããŠæå¹ã§ããã
æ¬çºæã¯ãã®äžé¢ã«æŒããŠã次ã®äžè¬åŒïŒïŒ
ã§è¡šããããïŒâã¯ããâïŒã»ïŒâãžããããã·
âïŒã»ïŒâãããããã³åã³ãã®ïŒã»ïŒâãžãšã¹
ãã«é¡ãæäŸããã
ã§è¡šããããïŒâã¯ããâïŒã»ïŒâãžããããã·
âïŒã»ïŒâãããããã³åã³ãã®ïŒã»ïŒâãžãšã¹
ãã«é¡ãæäŸããã
äžåŒã«æŒããŠïŒ²ã¯æ°ŽçŽ ãŸãã¯R1CïŒïŒ¯ïŒâïŒR1ã¯
ïŒâïŒççŽ ååãæããã¢ã«ãã«ã§ããïŒã§ã
ãã
ïŒâïŒççŽ ååãæããã¢ã«ãã«ã§ããïŒã§ã
ãã
ä»ã®äžé¢ã«æŒããŠãæ¬çºæã¯äžèšååç©ãšå°ãª
ããšãïŒçš®ã®å»è¬çã«èš±å®¹ããåŸãæ äœãšãããª
ãæ也ç¬å€çµæç©ãæäŸããã
ããšãïŒçš®ã®å»è¬çã«èš±å®¹ããåŸãæ äœãšãããª
ãæ也ç¬å€çµæç©ãæäŸããã
æ¬çºæã¯ããã«ä»ã®äžé¢ã«æŒããŠãæ²»çãå¿
èŠ
ãšããåºä¹³åç©ã«å¯Ÿãäžèšååç©ãå±ææäžãã
ããšãããªãåºä¹³åç©ã®è¡šç®çŽ°èå¢æ®ãé»æ¢ãã
æ¹æ³ãæäŸããã
ãšããåºä¹³åç©ã«å¯Ÿãäžèšååç©ãå±ææäžãã
ããšãããªãåºä¹³åç©ã®è¡šç®çŽ°èå¢æ®ãé»æ¢ãã
æ¹æ³ãæäŸããã
æ¬çºæã¯ããã«ä»ã®äžé¢ã«æŒããŠãïŒâã¯ãã
âïŒã»ïŒâãã¿ã«ã¢ã«ããããæ°Žæ§å¡©åºã®ååšäž
ã«ã°ãªãªããµãŒã«ãšåå¿ãããããŸãã¯ïŒâã¯ã
ãâïŒâããããã·âïŒã»ïŒâãããããã³ãïŒ
âã¯ããâïŒâããããã·âïŒã»ïŒâããããã
ã³ãŸãã¯ãããã®æ··åç©ãé žåå€ã§åŠçããããš
ã«ãã€ãŠãäžèšåŒïŒïŒã«æŒããŠïŒ²ãæ°ŽçŽ ã§ãã
ååç©ã調補ããæ¹æ³ãæäŸããã
âïŒã»ïŒâãã¿ã«ã¢ã«ããããæ°Žæ§å¡©åºã®ååšäž
ã«ã°ãªãªããµãŒã«ãšåå¿ãããããŸãã¯ïŒâã¯ã
ãâïŒâããããã·âïŒã»ïŒâãããããã³ãïŒ
âã¯ããâïŒâããããã·âïŒã»ïŒâããããã
ã³ãŸãã¯ãããã®æ··åç©ãé žåå€ã§åŠçããããš
ã«ãã€ãŠãäžèšåŒïŒïŒã«æŒããŠïŒ²ãæ°ŽçŽ ã§ãã
ååç©ã調補ããæ¹æ³ãæäŸããã
ããã«ä»ã®äžé¢ã«æŒããŠäžèšåŒïŒïŒã«æŒããŠ
ãæ°ŽçŽ ã§ããååç©ããšã¹ãã«åããããšãã
ãªããäžèšåŒïŒïŒã«æŒããŠïŒ²ãR1CïŒïŒ¯ïŒïŒR1
ã¯ïŒâïŒççŽ ååãæããã¢ã«ãã«ã§ãããïŒã§
ããååç©ã調補ããæ¹æ³ãæäŸããã
ãæ°ŽçŽ ã§ããååç©ããšã¹ãã«åããããšãã
ãªããäžèšåŒïŒïŒã«æŒããŠïŒ²ãR1CïŒïŒ¯ïŒïŒR1
ã¯ïŒâïŒççŽ ååãæããã¢ã«ãã«ã§ãããïŒã§
ããååç©ã調補ããæ¹æ³ãæäŸããã
調å€åã³æäž
æ¬çºæã«ä¿ãååç©ã¯ãä»ã®å±æé©çšå»è¬çµæ
ç©ãšåæ§ã«åžžæ³ã«åŸã€ãŠæäžåœ¢æ ã«èª¿å€ãããã
ãããã®çµæç©ã䜿çšåœ¢æ ã«ããã«ã¯çš®ã ã®å»è¬
çšæ äœãŸãã¯ããã¯ã«ãçšããŠåžžæ³ã«äŸã調å€ã
ãã°ããã
ç©ãšåæ§ã«åžžæ³ã«åŸã€ãŠæäžåœ¢æ ã«èª¿å€ãããã
ãããã®çµæç©ã䜿çšåœ¢æ ã«ããã«ã¯çš®ã ã®å»è¬
çšæ äœãŸãã¯ããã¯ã«ãçšããŠåžžæ³ã«äŸã調å€ã
ãã°ããã
æŠããŠåºä¹³åç©ãç¹ã«ããã«æŒãã也ç¬çºçŸ
ã¯ãæ£éšã«æ²»ççæå¹éãããªãã¡ãè¡šç®çŽ°èã®
å¢æ®ãäœæžããããïŒæ也ç¬å¹æïŒéã®æ¬çºæã«
ä¿ããããããã³ãæ¥è§Šããããããšã«ããæå¶
ãããã奜ãŸããã¯ããããããã³ããŸããåè¿°
ã®ããã«é©åœãªå»è¬è£œå€ã«èª¿è£œãã次ãã§æ£éšã«
æ¥è§Šããããããããããã³ã®æå¹æäžéã¯åŠçœ®
ãåããåºä¹³åç©åã³ãã®çç¶ã«äŸåããã§ãã
ãããå»è¬çµæç©ã®0.001ééïŒ ä¹è³10ééïŒ ã
奜ãŸããã¯0.01ééïŒ ä¹è³ïŒééïŒ ã§ããããã
ã®ãããªèª¿å€äžæ¿åºŠã«æŒããŠãæ²»ççã«æå¹ã§äž
ã€å¯äœçšãçããªãéãå³ã¡ãæ也ç¬åå¿ãæå¹
ã«ç€ºããæ£éšã«æªåœ±é¿ãåãŒããªãéãæ£éšã«é©
çšããã
ã¯ãæ£éšã«æ²»ççæå¹éãããªãã¡ãè¡šç®çŽ°èã®
å¢æ®ãäœæžããããïŒæ也ç¬å¹æïŒéã®æ¬çºæã«
ä¿ããããããã³ãæ¥è§Šããããããšã«ããæå¶
ãããã奜ãŸããã¯ããããããã³ããŸããåè¿°
ã®ããã«é©åœãªå»è¬è£œå€ã«èª¿è£œãã次ãã§æ£éšã«
æ¥è§Šããããããããããã³ã®æå¹æäžéã¯åŠçœ®
ãåããåºä¹³åç©åã³ãã®çç¶ã«äŸåããã§ãã
ãããå»è¬çµæç©ã®0.001ééïŒ ä¹è³10ééïŒ ã
奜ãŸããã¯0.01ééïŒ ä¹è³ïŒééïŒ ã§ããããã
ã®ãããªèª¿å€äžæ¿åºŠã«æŒããŠãæ²»ççã«æå¹ã§äž
ã€å¯äœçšãçããªãéãå³ã¡ãæ也ç¬åå¿ãæå¹
ã«ç€ºããæ£éšã«æªåœ±é¿ãåãŒããªãéãæ£éšã«é©
çšããã
æ¬çºæã®ãããããã³ã¯ãæ¢ç¥ã®é©åœãªå»è¬çš
ããã¯ã«ãçšããŠç¹ã«æå¹ãªå±æé©çšå»è¬çµæç©
ã調補ããããšãã§ãããåè¿°ã®ããã«ãããã
ãã³ã®æå¹éã¯èª¿å€åèšééã®çŽ0.001ééïŒ ä¹
è³çŽ10ééïŒ ã§ããã調å€çµæç©ã®æ®ãçŽ90éé
ïŒ ä¹è³çŽ99.999ééïŒ ã¯ãå±ææäžã«æå¹ãªå»è¬
調å€ã圢æããã®ã«é©åœãªå»è¬çã«èš±å®¹ããåŸã
溶å€åã³ãã®ä»ã®å»è¬çã«èš±å®¹ããåŸãæ·»å å€ã
å«ãã
ããã¯ã«ãçšããŠç¹ã«æå¹ãªå±æé©çšå»è¬çµæç©
ã調補ããããšãã§ãããåè¿°ã®ããã«ãããã
ãã³ã®æå¹éã¯èª¿å€åèšééã®çŽ0.001ééïŒ ä¹
è³çŽ10ééïŒ ã§ããã調å€çµæç©ã®æ®ãçŽ90éé
ïŒ ä¹è³çŽ99.999ééïŒ ã¯ãå±ææäžã«æå¹ãªå»è¬
調å€ã圢æããã®ã«é©åœãªå»è¬çã«èš±å®¹ããåŸã
溶å€åã³ãã®ä»ã®å»è¬çã«èš±å®¹ããåŸãæ·»å å€ã
å«ãã
å»è¬çã«èš±å®¹ããåŸã溶å€ã¯å®è³ªçã«éæ¯æ§äž
ã€äœ¿çšæ¡ä»¶ã«éåºæ¿æ§ã§ãã€ãŠãç²æ«ãã¯ãªãŒ
ã ãè»èãããŒã·ãšã³ãã²ã«ãçºæ³¡äœããšãŒããŸ
ã«ã溶液çã®æ§æ¥ããçšããããŠããè¬å€åœ¢æ ã«
容æã«èª¿å€ããããšãã§ãããç¹ã«é©åœãªæº¶å€ã«
ã¯æ°Žããšã¿ããŒã«ãã¢ã»ãã³ãã°ãªã»ãªã³ããã
ãã¬ã³ã«ãŒãããŒãããžã¡ãã«ã¹ã«ããã·ã
ïŒDMSOïŒã䞊ã³ã«ïŒã»ïŒâãããã¬ã³ãžãªãŒã«
ïŒäŸãã°ãããã¬ã³ã°ãªã³ãŒã«ïŒãïŒã»ïŒâããã
ã¬ã³ãžãªãŒã«ãååé100ä¹è³10000ã®ããªãšãã¬
ã³ã°ãªã³ãŒã«ããžãããã¬ã³ã°ãªã³ãŒã«çã®ã°ãª
ã³ãŒã«é¡ã䞊ã³ã«ãããã®æº¶å€ã®æ··åç©ãããã
ã€äœ¿çšæ¡ä»¶ã«éåºæ¿æ§ã§ãã€ãŠãç²æ«ãã¯ãªãŒ
ã ãè»èãããŒã·ãšã³ãã²ã«ãçºæ³¡äœããšãŒããŸ
ã«ã溶液çã®æ§æ¥ããçšããããŠããè¬å€åœ¢æ ã«
容æã«èª¿å€ããããšãã§ãããç¹ã«é©åœãªæº¶å€ã«
ã¯æ°Žããšã¿ããŒã«ãã¢ã»ãã³ãã°ãªã»ãªã³ããã
ãã¬ã³ã«ãŒãããŒãããžã¡ãã«ã¹ã«ããã·ã
ïŒDMSOïŒã䞊ã³ã«ïŒã»ïŒâãããã¬ã³ãžãªãŒã«
ïŒäŸãã°ãããã¬ã³ã°ãªã³ãŒã«ïŒãïŒã»ïŒâããã
ã¬ã³ãžãªãŒã«ãååé100ä¹è³10000ã®ããªãšãã¬
ã³ã°ãªã³ãŒã«ããžãããã¬ã³ã°ãªã³ãŒã«çã®ã°ãª
ã³ãŒã«é¡ã䞊ã³ã«ãããã®æº¶å€ã®æ··åç©ãããã
å±æé©çšã¯ãªãŒã ã¯æ°Žäžæ²¹åãŸãã¯æ²¹äžæ°Žåã®
ååºåœ¢ãšãã«ãžãšã³ãšããŠèª¿è£œããããšãã§ã
ããã¯ãªãŒã åºå€ã¯ïŒçžç³»ã®ãšãã«ãžãšã³ã§ãã€
ãŠãäŸãã°èèªãŸãã¯æ²¹ã®ãããªæ¶²äœãå°æ»Žãšã
ãŠããããããã³é¡ã«å¯Ÿããåºæ¬æº¶å€ãšããŠçšã
ãäŸãã°ã°ãªã³ãŒã«â氎溶å€å±€ã®ãããªä»ã®ç©è³ª
äžã«åæ£ãããã®ã§ãããã¯ãªãŒã åºå€ã«ã¯èèª
æã¢ã«ã³ãŒã«ãçé¢æŽ»æ§å€ãé±æ²¹ãŸãã¯ç³æ²¹ã䞊
ã³ã«æé žåå€ãæ¶æ¯å€ãŸãã¯çžæº¶å©å€çã®ãããª
ãã®ä»ã®ä»£è¡šçå»è¬è£å©å€ãæ··å ¥ããããšãã§ã
ãã代衚çãªã¯ãªãŒã åºå€ã®åŠæ¹ã¯æ¬¡ã®éãã§ã
ãã
ååºåœ¢ãšãã«ãžãšã³ãšããŠèª¿è£œããããšãã§ã
ããã¯ãªãŒã åºå€ã¯ïŒçžç³»ã®ãšãã«ãžãšã³ã§ãã€
ãŠãäŸãã°èèªãŸãã¯æ²¹ã®ãããªæ¶²äœãå°æ»Žãšã
ãŠããããããã³é¡ã«å¯Ÿããåºæ¬æº¶å€ãšããŠçšã
ãäŸãã°ã°ãªã³ãŒã«â氎溶å€å±€ã®ãããªä»ã®ç©è³ª
äžã«åæ£ãããã®ã§ãããã¯ãªãŒã åºå€ã«ã¯èèª
æã¢ã«ã³ãŒã«ãçé¢æŽ»æ§å€ãé±æ²¹ãŸãã¯ç³æ²¹ã䞊
ã³ã«æé žåå€ãæ¶æ¯å€ãŸãã¯çžæº¶å©å€çã®ãããª
ãã®ä»ã®ä»£è¡šçå»è¬è£å©å€ãæ··å ¥ããããšãã§ã
ãã代衚çãªã¯ãªãŒã åºå€ã®åŠæ¹ã¯æ¬¡ã®éãã§ã
ãã
æ°ŽïŒã°ãªã³ãŒã«æ··åç©ïŒã°ãªã³ãŒã«15ïŒ
ãŸãã¯ã
ã以äžå«æïŒ 50â99éééš èèªæã¢ã«ã³ãŒã« ïŒâ20 éã€ãªã³çé¢æŽ»æ§å€ ïŒâ10 é± æ²¹ ïŒâ10 代衚çå»è¬è£å©å€ ïŒâïŒ æŽ»æ§æå 0.001â10 èèªæã¢ã«ã³ãŒã«ãéã€ãªã³çé¢æŽ»æ§å€åã³ã
ã®ä»ã®è£å©å€ã¯ããŒã«ã»ã³ã®ç±³åœç¹èš±3934013ã«
èšèŒãããŠããã
ã以äžå«æïŒ 50â99éééš èèªæã¢ã«ã³ãŒã« ïŒâ20 éã€ãªã³çé¢æŽ»æ§å€ ïŒâ10 é± æ²¹ ïŒâ10 代衚çå»è¬è£å©å€ ïŒâïŒ æŽ»æ§æå 0.001â10 èèªæã¢ã«ã³ãŒã«ãéã€ãªã³çé¢æŽ»æ§å€åã³ã
ã®ä»ã®è£å©å€ã¯ããŒã«ã»ã³ã®ç±³åœç¹èš±3934013ã«
èšèŒãããŠããã
æ¬çºæã®ãããããã³é¡ã¯ãŸãå±æé©çšè»èãš
ããŠèª¿å€ããããšãã§ãããæ§æ¥ããçšããããŠ
ããè»èã¯ç¡æ°Žååºåœ¢çµæç©ã§ãã€ãŠé±æ²¹ãçœã¯
ã»ãªã³ãã°ãªã³ãŒã«ã®ãããªé©åœãªæº¶å€ãå«ã¿ã
ãã®è»èäžã«ã¯çé¢æŽ»æ§å€ïŒäŸãã°ã¹ãã³åã³ã
ã€ãŒã³ïŒãŸãã¯çŸæ¯èïŒã©ããªã³ïŒã®ãããªå»è¬
çã«èš±å®¹ããåŸãé©åœãªæ·»å å€åã³ãããã¬ã³ã«
ãŒãããŒããæ··å ¥ããããšãã§ãããŸãæé žåå€
ã®ãããªå®å®å€ãã®ä»ã®åè¿°ã®ãããªè£å©å€ãæ··
å ¥ããããšãã§ãããæ§æ¥ããçšããããŠããè»
èåºå€ã®ä»£è¡šçïŒäŸã瀺ããšæ¬¡ã®éãã§ããã
ããŠèª¿å€ããããšãã§ãããæ§æ¥ããçšããããŠ
ããè»èã¯ç¡æ°Žååºåœ¢çµæç©ã§ãã€ãŠé±æ²¹ãçœã¯
ã»ãªã³ãã°ãªã³ãŒã«ã®ãããªé©åœãªæº¶å€ãå«ã¿ã
ãã®è»èäžã«ã¯çé¢æŽ»æ§å€ïŒäŸãã°ã¹ãã³åã³ã
ã€ãŒã³ïŒãŸãã¯çŸæ¯èïŒã©ããªã³ïŒã®ãããªå»è¬
çã«èš±å®¹ããåŸãé©åœãªæ·»å å€åã³ãããã¬ã³ã«
ãŒãããŒããæ··å ¥ããããšãã§ãããŸãæé žåå€
ã®ãããªå®å®å€ãã®ä»ã®åè¿°ã®ãããªè£å©å€ãæ··
å ¥ããããšãã§ãããæ§æ¥ããçšããããŠããè»
èåºå€ã®ä»£è¡šçïŒäŸã瀺ããšæ¬¡ã®éãã§ããã
çœã¯ã»ãªã³ 40â94éééš
é± æ²¹ ïŒâ20
ã°ãªã³ãŒã«æº¶å€ ïŒâ15
çé¢æŽ»æ§å€ ïŒâ10
å®å®å€ ïŒâ10
掻æ§æå 0.001â10.0
ãããã¬ã³ã«ãŒãããŒããçšãããã®ä»ã®é©åœ
ãªè»èåºå€ã¯ç±³åœç¹èš±4017615ïŒ1977幎ïŒæ12æ¥
ç¹èš±ãã·ã€ã¹ããªçãå称ïŒãããã¬ã³ã«ãŒãã
ãŒãè»èããã¯ã«ïŒåã³ç±³åœç¹èš±3924004ïŒ1975
幎12æïŒæ¥ç¹èš±ããã€ã³çãå称ïŒèèªæã¢ã«ã³
ãŒã«âãããã¬ã³ã«ãŒãããŒãâã°ãªã³ãŒã«æº¶å€
ã¯ãªãŒã ããã¯ã«ïŒã«èšèŒãããŠããããããã®
åºé¡ã®å€ãã®èšèŒã¯é¢é£ãæ·±ãã®ã§æ¬æ现æžã«æ
çšããŠããããããã¬ã³ã«ãŒãããŒããå«æãã
代衚çè»èåºå€ã®ïŒäŸã瀺ããšæ¬¡ã®éãã§ããã
ãªè»èåºå€ã¯ç±³åœç¹èš±4017615ïŒ1977幎ïŒæ12æ¥
ç¹èš±ãã·ã€ã¹ããªçãå称ïŒãããã¬ã³ã«ãŒãã
ãŒãè»èããã¯ã«ïŒåã³ç±³åœç¹èš±3924004ïŒ1975
幎12æïŒæ¥ç¹èš±ããã€ã³çãå称ïŒèèªæã¢ã«ã³
ãŒã«âãããã¬ã³ã«ãŒãããŒãâã°ãªã³ãŒã«æº¶å€
ã¯ãªãŒã ããã¯ã«ïŒã«èšèŒãããŠããããããã®
åºé¡ã®å€ãã®èšèŒã¯é¢é£ãæ·±ãã®ã§æ¬æ现æžã«æ
çšããŠããããããã¬ã³ã«ãŒãããŒããå«æãã
代衚çè»èåºå€ã®ïŒäŸã瀺ããšæ¬¡ã®éãã§ããã
掻æ§æå 0.001â10.0éééš
ãããã¬ã³ã«ãŒãããŒã ïŒâ10
溶 å€ ïŒâ10
çé¢æŽ»æ§å€ ïŒâ10
çœã¯ã»ãªã³ 70â97
é©åœãªæº¶å€ãçé¢æŽ»æ§å€ãå®å®å€ãªã©ã¯ç±³åœç¹
èš±3934013ã«é瀺ãããŠããããããã¯ãã®æ现
æžã«æŒããŠåŒçšããŠããã
èš±3934013ã«é瀺ãããŠããããããã¯ãã®æ现
æžã«æŒããŠåŒçšããŠããã
æ§æ¥ããçšããããŠãããã®ã§ã¯ãªããé©åœãª
å±æé©çšç¡æ°Žãæ°ŽæŽå¯èœãªãè»èåãåºå€ã¯ç±³åœ
ç¹èš±3592930ïŒã«ããåã³ãã€ãã³ïŒã«èšèŒãã
ãŠããããããåºå€ãçšãããã®çºæã®ä»£è¡šççµ
æã®ïŒäŸã瀺ããšæ¬¡ã®éãã§ããã
å±æé©çšç¡æ°Žãæ°ŽæŽå¯èœãªãè»èåãåºå€ã¯ç±³åœ
ç¹èš±3592930ïŒã«ããåã³ãã€ãã³ïŒã«èšèŒãã
ãŠããããããåºå€ãçšãããã®çºæã®ä»£è¡šççµ
æã®ïŒäŸã瀺ããšæ¬¡ã®éãã§ããã
ã°ãªã³ãŒã«æº¶å€ 40â35éééš
èèªæã¢ã«ã³ãŒã« 15â45
çžæº¶æ§å¯å¡å€ ïŒâ15
çžæº¶æ§ã«ãããªã³ã°å€ ïŒâ15
浞éå€ ïŒâ20
掻æ§æå 0.001â10.0
調補æ¹æ³
åèšåŒïŒïŒã§è¡šãããããããããã³ã«æŒã
ãŠïŒ²ãã§ããååç©ã¯äžè¬ã«åè¿°ã®ãŠãšã€ã¬ã³
ãç¹èš±ã«é瀺ãããæ¹æ³ã«åŸã€ãŠèª¿è£œããããã
ã®ååç©ã®èª¿è£œã¯æ¬¡ã®åå¿åºåã«ããè¡šããããš
ãã§ããã
ãŠïŒ²ãã§ããååç©ã¯äžè¬ã«åè¿°ã®ãŠãšã€ã¬ã³
ãç¹èš±ã«é瀺ãããæ¹æ³ã«åŸã€ãŠèª¿è£œããããã
ã®ååç©ã®èª¿è£œã¯æ¬¡ã®åå¿åºåã«ããè¡šããããš
ãã§ããã
åå¿åºå ïŒ
æåã«ãå¡©çŽ çœ®æãªã«ãœâãã·ã¬ã³ïŒååç©
ïŒïŒã®ã¡ãã«åºãçŽæ¥ããã²ã³åãããèçŽ ãæ
ãæãŸãããã眮æåºã§ããå Žåãããããã®ã¡
ãã«åºã«ãããïŒçœ®æããã®ãæã䟿å®çã§ã
ããåå¿ã¯èçŽ åå€ãšããŠïŒ®âããã¢ã¹ã¯ã·ã³ã€
ãããçšããŠå®¹æã«èµ·ãããäŸãã°ãDjerassiã
Chem.Revs.ã43ã271ïŒ1948ïŒãåç §ããã
ãã次ãã§ååç©ïŒãå³ã¡ïŒâã¯ããâã¢ã«ã
ã¢ãã¢ã«ãã¢ãããŒã¿ãããŒã¿âããã©ããã¢â
ãªã«ãœâãã·ã¬ã³ããé©åœãªè§Šåªã®ååšäžã«ãžãš
ã ãžããã²ã³åç©ãå æ°Žå解ããå Žåã«ç¥ãããŠ
ããæ¹æ³ã§è±ããã²ã³åããã觊åªã«ã¯ãäŸã
ã°ãçé žã«ã«ã·ãŠã ãç¡«é žãã¢ã«ããªãªã³åã³
çš®ã ã®éå¡©ããããéåžžé ¢é žãååç©ïŒåã³é ¢é ž
éãããªãæ··åç©ãå ç±ãããšååç©ïŒãè±ãã
ã²ã³åãããŠååç©ïŒã«è»¢æãããååç©ïŒã¯é
åžžéçé žãããªãŠã ã®ãããªå¡©åºã§åŠçãããšå®¹
æã«ååç©ïŒã«è»¢æãããã次ãã§ïŒâã¯ããâ
ïŒã»ïŒâãã¿ã«ã¢ã«ãããäžéäœïŒãæ¬çºæã®æ¹
æ³ã«åŸã€ãŠã°ãªãªããµãŒã«ïŒOHCCHOïŒãšåå¿
ãããŠïŒâã¯ããâïŒã»ïŒâãžããããã·âïŒã»
ïŒâãããããã³ååç©ïŒã«è»¢æããããã®åå¿
ã¯äžè¿°ã®ãŠãšã€ã¬ã³ãã®å ¬éç¹èš±åºé¡859008ã«ã
ãçšåºŠè©³çŽ°ã«å ±åãããŠãããäžè¬ã«ãã®åå¿ã¯
æ°Žæ§å¡©åºäžPHïŒä¹è³12åã³æž©åºŠ10ä¹è³80âã«æŒã
ãŠè¡ããçšããå¡©åºã«ã¯çé žã¢ã«ã«ãªéå±å¡©ãé
çé žã¢ã«ã«ãªéå±å¡©åã³ã¢ã«ã«ãªéå±æ°Žé žåç©äžŠ
ã³ã«ïŒçŽã¢ãã³ãªã©ãããã
ïŒïŒã®ã¡ãã«åºãçŽæ¥ããã²ã³åãããèçŽ ãæ
ãæãŸãããã眮æåºã§ããå Žåãããããã®ã¡
ãã«åºã«ãããïŒçœ®æããã®ãæã䟿å®çã§ã
ããåå¿ã¯èçŽ åå€ãšããŠïŒ®âããã¢ã¹ã¯ã·ã³ã€
ãããçšããŠå®¹æã«èµ·ãããäŸãã°ãDjerassiã
Chem.Revs.ã43ã271ïŒ1948ïŒãåç §ããã
ãã次ãã§ååç©ïŒãå³ã¡ïŒâã¯ããâã¢ã«ã
ã¢ãã¢ã«ãã¢ãããŒã¿ãããŒã¿âããã©ããã¢â
ãªã«ãœâãã·ã¬ã³ããé©åœãªè§Šåªã®ååšäžã«ãžãš
ã ãžããã²ã³åç©ãå æ°Žå解ããå Žåã«ç¥ãããŠ
ããæ¹æ³ã§è±ããã²ã³åããã觊åªã«ã¯ãäŸã
ã°ãçé žã«ã«ã·ãŠã ãç¡«é žãã¢ã«ããªãªã³åã³
çš®ã ã®éå¡©ããããéåžžé ¢é žãååç©ïŒåã³é ¢é ž
éãããªãæ··åç©ãå ç±ãããšååç©ïŒãè±ãã
ã²ã³åãããŠååç©ïŒã«è»¢æãããååç©ïŒã¯é
åžžéçé žãããªãŠã ã®ãããªå¡©åºã§åŠçãããšå®¹
æã«ååç©ïŒã«è»¢æãããã次ãã§ïŒâã¯ããâ
ïŒã»ïŒâãã¿ã«ã¢ã«ãããäžéäœïŒãæ¬çºæã®æ¹
æ³ã«åŸã€ãŠã°ãªãªããµãŒã«ïŒOHCCHOïŒãšåå¿
ãããŠïŒâã¯ããâïŒã»ïŒâãžããããã·âïŒã»
ïŒâãããããã³ååç©ïŒã«è»¢æããããã®åå¿
ã¯äžè¿°ã®ãŠãšã€ã¬ã³ãã®å ¬éç¹èš±åºé¡859008ã«ã
ãçšåºŠè©³çŽ°ã«å ±åãããŠãããäžè¬ã«ãã®åå¿ã¯
æ°Žæ§å¡©åºäžPHïŒä¹è³12åã³æž©åºŠ10ä¹è³80âã«æŒã
ãŠè¡ããçšããå¡©åºã«ã¯çé žã¢ã«ã«ãªéå±å¡©ãé
çé žã¢ã«ã«ãªéå±å¡©åã³ã¢ã«ã«ãªéå±æ°Žé žåç©äžŠ
ã³ã«ïŒçŽã¢ãã³ãªã©ãããã
åèšåŒïŒïŒã§è¡šããããååç©ã«æŒããŠïŒ²ã
æ°ŽçŽ ã§ãããã®ã¯ãŸããïŒâã¯ããâïŒâããã
ãã·âïŒã»ïŒâãããããã³ãŸãã¯ïŒâã¯ããâ
ïŒâããããã·âïŒã»ïŒâãããããã³ã次ã®å
å¿åºåïŒã«åŸã€ãŠé žåããããšã«ãã調補ããã
æ°ŽçŽ ã§ãããã®ã¯ãŸããïŒâã¯ããâïŒâããã
ãã·âïŒã»ïŒâãããããã³ãŸãã¯ïŒâã¯ããâ
ïŒâããããã·âïŒã»ïŒâãããããã³ã次ã®å
å¿åºåïŒã«åŸã€ãŠé žåããããšã«ãã調補ããã
åå¿åºå ïŒ
åæå
é§ç©è³ªã¯å
±ã«æ¢ç¥ååç©ã§ãããäŸã
ã°ãJ.Am.Chem.Soc.71ã3615â17ïŒ1949ïŒåã³
J.Am.Chem.Soc.75ã2910â15ïŒ1953ïŒãåç §ã
ããããé žååå¿ã¯ãå¡©åºæ§éé žåæ°ŽçŽ äžŠã³ã«é
é ¢é žãïœâã¯ããéå®æ¯éŠé žãã¢ã«ã«ãªæ°Žæº¶æ¶²ã§
æ°Žæ§åããããšãªã·ã¢ã³é žã«ãªãŠã³ãªã©ã®éé žã
çšããŠæ¢ç¥ã®æ¹æ³ã«åŸã€ãŠé©åœã«è¡ãããšãã§ã
ãã奜ãŸããé žåå€ã¯å¡©åºæ§éé žåæ°ŽçŽ ã§ããã
ã°ãJ.Am.Chem.Soc.71ã3615â17ïŒ1949ïŒåã³
J.Am.Chem.Soc.75ã2910â15ïŒ1953ïŒãåç §ã
ããããé žååå¿ã¯ãå¡©åºæ§éé žåæ°ŽçŽ äžŠã³ã«é
é ¢é žãïœâã¯ããéå®æ¯éŠé žãã¢ã«ã«ãªæ°Žæº¶æ¶²ã§
æ°Žæ§åããããšãªã·ã¢ã³é žã«ãªãŠã³ãªã©ã®éé žã
çšããŠæ¢ç¥ã®æ¹æ³ã«åŸã€ãŠé©åœã«è¡ãããšãã§ã
ãã奜ãŸããé žåå€ã¯å¡©åºæ§éé žåæ°ŽçŽ ã§ããã
åèšåŒïŒïŒã§è¡šããããååç©ã®ãã¡ïŒ²ã
R1CïŒïŒ¯ïŒâã§ãããã®ã¯æ¢ç¥ã®æ¹æ³ã«åŸã€ãŠ
ïŒã»ïŒâãžããããã·ååç©ããšã¹ãã«åããã
ãšã«ãã調補ãããäŸãã°ãã¢ã·ã«ç¡æ°Žç©ãŸãã¯
ã¢ã·ã«å¡©åç©ã®ããªãžã³æº¶æ¶²ãŸãã¯ããªãžã³ãã
ãã¯ããªãšãã«ã¢ãã³ã®ãããªïŒçŽå¡©åºãå«æã
ãããã©ããããã©ã³ã®ãããªäžæŽ»æ§æº¶å€æº¶æ¶²ã§
åŠçããããŸãã¯å¡©åäºéãç¡«é žãããã¯70ïŒ é
å¡©çŽ é žã®ãããªé žèåªã®ååšäžã«ã¢ã·ã«ç¡æ°Žç©ã§
åŠçããã
R1CïŒïŒ¯ïŒâã§ãããã®ã¯æ¢ç¥ã®æ¹æ³ã«åŸã€ãŠ
ïŒã»ïŒâãžããããã·ååç©ããšã¹ãã«åããã
ãšã«ãã調補ãããäŸãã°ãã¢ã·ã«ç¡æ°Žç©ãŸãã¯
ã¢ã·ã«å¡©åç©ã®ããªãžã³æº¶æ¶²ãŸãã¯ããªãžã³ãã
ãã¯ããªãšãã«ã¢ãã³ã®ãããªïŒçŽå¡©åºãå«æã
ãããã©ããããã©ã³ã®ãããªäžæŽ»æ§æº¶å€æº¶æ¶²ã§
åŠçããããŸãã¯å¡©åäºéãç¡«é žãããã¯70ïŒ é
å¡©çŽ é žã®ãããªé žèåªã®ååšäžã«ã¢ã·ã«ç¡æ°Žç©ã§
åŠçããã
次ã®èª¿è£œäŸïŒåã³ïŒäžŠã³ã«å®æœäŸïŒåã³ïŒã¯å
èšåå¿åºåïŒã«å¯Ÿå¿ããã
èšåå¿åºåïŒã«å¯Ÿå¿ããã
èª¿è£œäŸ ïŒ
ïŒâã¯ããâαã»Î±ã»Î²ã»Î²âããã©ããã¢â
âãã·ã¬ã³ 250ã¯ããã¿ã³ã°ã¹ãã³èµ€å€ç·ã©ã³ããçšããŠ
ïŒâã¯ããââãã·ã¬ã³ïŒååç©ïŒã14.0ïœã
0.1ã¢ã«ïŒãšåçµæ¶ããã°ããã®ïŒ®âããã¢ã¹ã¯
ã·ã³ã€ããïŒ80ïœã0.45ã¢ã«ïŒã®æ··åç©ã®åå¡©å
çé žïŒ1LïŒæº¶æ¶²ã«2.5æéç §å°ãããèµ€å€ç·ã©ã³
ãã¯æº¶å€ãããããã«éæµããããã«äœçœ®ããã
ãã次ãã§åºäœãå¥ãã液ãæžå§äžã«æ¿çž®
ããçµæ¶æ®æž£ãã€ãœãããããŒã«ããåçµæ¶ããŠ
ïŒâã¯ããâαã»Î±ã»Î²ã»Î²âããã©ããã¢â
âãã·ã¬ã³ïŒååç©ïŒïŒ34ïœïŒ75ïŒ ïŒãåŸããè
ç¹ïŒm.p.ïŒ108â111âãBull.Soc.Chim.ã2966
ïŒ1966ïŒãmp114ããã
âãã·ã¬ã³ 250ã¯ããã¿ã³ã°ã¹ãã³èµ€å€ç·ã©ã³ããçšããŠ
ïŒâã¯ããââãã·ã¬ã³ïŒååç©ïŒã14.0ïœã
0.1ã¢ã«ïŒãšåçµæ¶ããã°ããã®ïŒ®âããã¢ã¹ã¯
ã·ã³ã€ããïŒ80ïœã0.45ã¢ã«ïŒã®æ··åç©ã®åå¡©å
çé žïŒ1LïŒæº¶æ¶²ã«2.5æéç §å°ãããèµ€å€ç·ã©ã³
ãã¯æº¶å€ãããããã«éæµããããã«äœçœ®ããã
ãã次ãã§åºäœãå¥ãã液ãæžå§äžã«æ¿çž®
ããçµæ¶æ®æž£ãã€ãœãããããŒã«ããåçµæ¶ããŠ
ïŒâã¯ããâαã»Î±ã»Î²ã»Î²âããã©ããã¢â
âãã·ã¬ã³ïŒååç©ïŒïŒ34ïœïŒ75ïŒ ïŒãåŸããè
ç¹ïŒm.p.ïŒ108â111âãBull.Soc.Chim.ã2966
ïŒ1966ïŒãmp114ããã
èª¿è£œäŸ ïŒ
ïŒâã¯ããâïŒã»ïŒâãã¿ã«ã¢ã«ããã
ååç©ïŒïŒ22.8ïœã0.05ã¢ã«ïŒãé
¢é
žéïŒ36.6
ïœã0.22ã¢ã«ïŒåã³æ°·é ¢é žïŒ500mlïŒã®æ··åç©ã
éæµæ¡ä»¶äžã«1.5æéå ç±ãããéå¡©ãå¥ãã
ã¯ãããã«ã ã§æŽæµããéãã液ãæžå§äžã«æ¿
瞮也涞ãããæ®æž£ã«ãã«ãšã³ãçšããŠæåŸã®çè·¡
éã®é ¢é žãèžçºé€å»ãããåŸãããåçµæ¶æ§ç©è³ª
ïŒããžãªããµã³ïŒ500mlïŒã«æº¶è§£ããããã«çé ž
ãããªãŠã ïŒ13ïœïŒã®æ°ŽïŒ500mlïŒæº¶æ¶²ãå ã
ããæ··åç©ã22âã«æŒããŠ20åéæ¿ããæ¯çªãã
å¡©åãããªãŠã ã飜åãããã次ãã§é ¢é žãšãã«
ïŒïŒÃ500mlïŒã§æœåºãããéããææ©æœåºç©ãã
ã©ã€ã³ã§æŽæµãïŒïŒÃ400mlïŒãMgSO4ã§ä¹Ÿç¥ã
æžå§äžã«æ¿çž®ããŠãã»ãŒçŽç²ãªïŒâã¯ããâïŒã»
ïŒâãã¿ã«ã¢ã«ããã6.0ïœïŒ72ïŒ ïŒãåŸãã75
âåã³0.05mmHgã«æŒããŠæè¯ãããšããååç©
ïŒ5.4ïœãåŸããm.p.72â76âã
ïœã0.22ã¢ã«ïŒåã³æ°·é ¢é žïŒ500mlïŒã®æ··åç©ã
éæµæ¡ä»¶äžã«1.5æéå ç±ãããéå¡©ãå¥ãã
ã¯ãããã«ã ã§æŽæµããéãã液ãæžå§äžã«æ¿
瞮也涞ãããæ®æž£ã«ãã«ãšã³ãçšããŠæåŸã®çè·¡
éã®é ¢é žãèžçºé€å»ãããåŸãããåçµæ¶æ§ç©è³ª
ïŒããžãªããµã³ïŒ500mlïŒã«æº¶è§£ããããã«çé ž
ãããªãŠã ïŒ13ïœïŒã®æ°ŽïŒ500mlïŒæº¶æ¶²ãå ã
ããæ··åç©ã22âã«æŒããŠ20åéæ¿ããæ¯çªãã
å¡©åãããªãŠã ã飜åãããã次ãã§é ¢é žãšãã«
ïŒïŒÃ500mlïŒã§æœåºãããéããææ©æœåºç©ãã
ã©ã€ã³ã§æŽæµãïŒïŒÃ400mlïŒãMgSO4ã§ä¹Ÿç¥ã
æžå§äžã«æ¿çž®ããŠãã»ãŒçŽç²ãªïŒâã¯ããâïŒã»
ïŒâãã¿ã«ã¢ã«ããã6.0ïœïŒ72ïŒ ïŒãåŸãã75
âåã³0.05mmHgã«æŒããŠæè¯ãããšããååç©
ïŒ5.4ïœãåŸããm.p.72â76âã
å®æœäŸ ïŒ
ïŒâã¯ããâïŒã»ïŒâãžããããã·âïŒã»ïŒâ
ãããããã³ ïŒâã¯ããâïŒã»ïŒâãã¿ã«ã¢ã«ãããïŒ4.88
ïœã29ïœã¢ã«ïŒã®æº¶æ¶²ãé žçŽ é°å²æ°äžã§æ¿ããæ¹
æããªãããããã«çé žãããªãŠã ïŒ12.3ïœïŒã®
æ°ŽïŒ290mlïŒæº¶æ¶²ã宀枩ã«æŒããŠå ããçŽã¡ã«é
äºç¡«é žã°ãªãªããµãŒã«ïŒ16.4ïœã58ïœã¢ã«ïŒåã³
ã·ã¢ã³åã«ãªãŠã ïŒ1.88ïœã29ïœã¢ã«ïŒã®æ°Ž
ïŒ290mlïŒæº¶æ¶²ãïŒåéã«äºã€ãŠå ãããåå¿æ··å
ç©ãããã«é žçŽ é°å²æ°äžã§ïŒåéæ¹æããã次ã
ã§ã6Nå¡©é žïŒ50mlïŒã§åŠçãã氷塩济äžã§å·åŽ
ãããã«æ°ŽïŒ500mlïŒã§åžéãããçµæ¶çæç©ã
éããŠéããæ°ŽæŽãã也ç¥ããæ°ŽïŒã¡ã¿ããŒã«
ïŒïŒïŒïŒïŒããåçµæ¶ããŠïŒâã¯ããâïŒã»ïŒâ
ãžããããã·âïŒã»ïŒâãããããã³3.56ïœïŒ55
ïŒ ïŒãåŸããm.p.228â229ãã
ãããããã³ ïŒâã¯ããâïŒã»ïŒâãã¿ã«ã¢ã«ãããïŒ4.88
ïœã29ïœã¢ã«ïŒã®æº¶æ¶²ãé žçŽ é°å²æ°äžã§æ¿ããæ¹
æããªãããããã«çé žãããªãŠã ïŒ12.3ïœïŒã®
æ°ŽïŒ290mlïŒæº¶æ¶²ã宀枩ã«æŒããŠå ããçŽã¡ã«é
äºç¡«é žã°ãªãªããµãŒã«ïŒ16.4ïœã58ïœã¢ã«ïŒåã³
ã·ã¢ã³åã«ãªãŠã ïŒ1.88ïœã29ïœã¢ã«ïŒã®æ°Ž
ïŒ290mlïŒæº¶æ¶²ãïŒåéã«äºã€ãŠå ãããåå¿æ··å
ç©ãããã«é žçŽ é°å²æ°äžã§ïŒåéæ¹æããã次ã
ã§ã6Nå¡©é žïŒ50mlïŒã§åŠçãã氷塩济äžã§å·åŽ
ãããã«æ°ŽïŒ500mlïŒã§åžéãããçµæ¶çæç©ã
éããŠéããæ°ŽæŽãã也ç¥ããæ°ŽïŒã¡ã¿ããŒã«
ïŒïŒïŒïŒïŒããåçµæ¶ããŠïŒâã¯ããâïŒã»ïŒâ
ãžããããã·âïŒã»ïŒâãããããã³3.56ïœïŒ55
ïŒ ïŒãåŸããm.p.228â229ãã
åæçµæãC10H5ClO4ïŒ224.60ïŒãšããŠã®èšç®
å€ïŒïŒ£ã53.48ïŒïŒšã2.24ãå®æž¬å€ïŒïŒ£ã53.50ïŒ
ã2.30ã
å€ïŒïŒ£ã53.48ïŒïŒšã2.24ãå®æž¬å€ïŒïŒ£ã53.50ïŒ
ã2.30ã
å®æœäŸ ïŒ
è¡šç®çŽ°èå¢æ®ãæå¶ããæ¢ç¥ã®æ也ç¬å€ã®è¬å¹
ãè©Šéšããçºãè¥ãéã©ãããçšããŠåç©å®éšã
è¡ã€ãããã®å®éšã«æŒããŠè©Šéšåç©ã®ïŒæ¹ã®èè ¹
ã®ç®èã«è©Šéšè¬å€ã®é©åœãªæ äœæº¶æ¶²ãé©çšããä»
æ¹ã®èè ¹ã«ã¯å¯Ÿç §ãšããŠæ äœåç¬ãé©çšãããçµ
æç©ãïŒåãŸãã¯ïŒå以äžé©çšããåŸé©åœãªæé
ééã眮ããŠåç©ããç®èãé€å»ããåŠçœ®åºåå
ã³å¯Ÿç §åºåããããããæ¡åããç®èæ ãè©Šéšç®¡
å ã§ããªããŠãŒã æšèä»ããããžã³ïŒDNAåæ
å é§ç©è³ªïŒãçšããŠå¹é€ãããåŠçœ®åºååã³å¯Ÿç §
åºåããæ¡åããç®èæ ã®DNAäžãžç·šå ¥çµåã
ãæŸå°ç·æšèä»ããããžã³ã®çžå¯Ÿéã¯DNAåæ
æå¶ã®çšåºŠã®ç®å®ãã²ããŠã¯åŠçœ®ã«å¯Ÿå¿ããŠèµ·ã
ã€ãè¡šç®çŽ°èå¢æ®æå¶ã®ç®å®ãšãªãã
ãè©Šéšããçºãè¥ãéã©ãããçšããŠåç©å®éšã
è¡ã€ãããã®å®éšã«æŒããŠè©Šéšåç©ã®ïŒæ¹ã®èè ¹
ã®ç®èã«è©Šéšè¬å€ã®é©åœãªæ äœæº¶æ¶²ãé©çšããä»
æ¹ã®èè ¹ã«ã¯å¯Ÿç §ãšããŠæ äœåç¬ãé©çšãããçµ
æç©ãïŒåãŸãã¯ïŒå以äžé©çšããåŸé©åœãªæé
ééã眮ããŠåç©ããç®èãé€å»ããåŠçœ®åºåå
ã³å¯Ÿç §åºåããããããæ¡åããç®èæ ãè©Šéšç®¡
å ã§ããªããŠãŒã æšèä»ããããžã³ïŒDNAåæ
å é§ç©è³ªïŒãçšããŠå¹é€ãããåŠçœ®åºååã³å¯Ÿç §
åºåããæ¡åããç®èæ ã®DNAäžãžç·šå ¥çµåã
ãæŸå°ç·æšèä»ããããžã³ã®çžå¯Ÿéã¯DNAåæ
æå¶ã®çšåºŠã®ç®å®ãã²ããŠã¯åŠçœ®ã«å¯Ÿå¿ããŠèµ·ã
ã€ãè¡šç®çŽ°èå¢æ®æå¶ã®ç®å®ãšãªãã
äžè¿°ã®æ¹æ³ã«åŸã€ãŠã©ãããçšããŠæ¬çºæã«ä¿
ãçµæç©ã«ã€ããŠè©Šéšãããè©Šéšæ¹æ³ã¯æ¬¡ã®éã
ã§ããã
ãçµæç©ã«ã€ããŠè©Šéšãããè©Šéšæ¹æ³ã¯æ¬¡ã®éã
ã§ããã
è©Šéšã®24æéåã«éã¢ã«ããã©ããïŒçåŸ21â
22æ¥ïŒã®èäžåã³äž¡èè ¹ãé»æ°ããªã«ã³ãçšããŠ
åæ¯ãããïŒâã¯ããâïŒã»ïŒâãžããããã·â
ïŒã»ïŒâãããããã³ããšã¿ããŒã«ïŒEtOHïŒã
ã¢ã»ãã³ããžã¡ãã«ã¹ã«ããã·ãïŒDMSOïŒãã
ãªãæ··åç©ãŸãã¯DMSOãšEtOHãããªãæ··åç©
ã«æº¶è§£ãããè©Šéšè¬å€ãå«æãã溶液ïŒ0.10mlïŒ
ãããã¿ã®å³èè ¹ãžãæ äœåç¬ïŒ0.10mlïŒãå·Šè
è ¹ãžããããé©çšãããé©çšåºåã¯çŽ10å¹³æ¹cmã§
ãã€ããé©çšã¯ç¬¬ïŒãïŒåã³ïŒæ¥ã®ååïŒæåã³
ååŸïŒæã«è¡ã€ãã第ïŒæ¥ã«äºé žåççŽ ãçšããŠ
ã©ãããçªæ¯æ»ãããèäžåã³äž¡èè ¹ããç®èå
å šäœãé€å»ãããç®äžèèªåã³çèãããåãã
è¡šç®åã³è£ç®ãããªãçŽåŸïŒmmã®ç®èæ ãå¯Ÿç §è
è ¹åºåããïŒæãåŠçœ®èè ¹åºåããïŒæãããã
ææãããããªããŠãŒã æšèä»ããããžã³ïŒ10ã
ã€ã¯ãããŠãªãŒïŒmlïŒãå«æãããã«ããã³
ïŒDulbeccoïŒã®å€æ§ã€ãŒã°ã«ã¡ãžãŠãŒã ïŒmlã«äž
èšç®èæ ãããããæµ®ãããŠ37ãã§å¹é€ãããïŒ
æéå¹é€ããåŸãç®èæ ãåçµãã解ãããåžå
çŽã§ä¹Ÿç¥ãã30ïŒ é ¢é žæ°Žæº¶æ¶²ã§ïŒåç¡æ°Žãšã¿ããŒ
ã«äžã§ïŒå泚ããæªçµåããªããŠãŒã æšèä»ãã
ããžã³ãé€å»ãããæŽæµããç®èæ ãNCSå¯æº¶
åå€äžã§æž©æµžããŠãDNAäžã«ç·šå ¥çµåããããª
ããŠãŒã æšèä»ããããžã³ã®éã枬å®ããçºã®ã·
ã³ãã¬ãŒã·ãšã³èšæ°æº¶æ¶²äœãšãããåŠçœ®ã«ããæ
å¶å¹æã¯ãåŠçœ®åºåããæ¡åããç®èæ äžã«ç·šå ¥
çµåãããæŸå°èœã®éãšå¯Ÿç §èè ¹åºåããæ¡åã
ãç®èæ äžãžç·šå ¥çµåããæŸå°èœã®éãæ¯èŒãã
ããšã«ãã枬å®ãããããããã®è©Šéšã«å°ããšã
ïŒå¹ã®åç©ãçšãããããŒã¿ã¯ããããã®åç©ã«
ã€ããŠãåŠçåºåã«æŒããå¹³åæŸå°èœãšå¯Ÿç §åºå
ã«æŒããå¹³åæŸå°èœãšã®æ¯ïŒÃ100ïŒãšããŠèšé²
ããã
22æ¥ïŒã®èäžåã³äž¡èè ¹ãé»æ°ããªã«ã³ãçšããŠ
åæ¯ãããïŒâã¯ããâïŒã»ïŒâãžããããã·â
ïŒã»ïŒâãããããã³ããšã¿ããŒã«ïŒEtOHïŒã
ã¢ã»ãã³ããžã¡ãã«ã¹ã«ããã·ãïŒDMSOïŒãã
ãªãæ··åç©ãŸãã¯DMSOãšEtOHãããªãæ··åç©
ã«æº¶è§£ãããè©Šéšè¬å€ãå«æãã溶液ïŒ0.10mlïŒ
ãããã¿ã®å³èè ¹ãžãæ äœåç¬ïŒ0.10mlïŒãå·Šè
è ¹ãžããããé©çšãããé©çšåºåã¯çŽ10å¹³æ¹cmã§
ãã€ããé©çšã¯ç¬¬ïŒãïŒåã³ïŒæ¥ã®ååïŒæåã³
ååŸïŒæã«è¡ã€ãã第ïŒæ¥ã«äºé žåççŽ ãçšããŠ
ã©ãããçªæ¯æ»ãããèäžåã³äž¡èè ¹ããç®èå
å šäœãé€å»ãããç®äžèèªåã³çèãããåãã
è¡šç®åã³è£ç®ãããªãçŽåŸïŒmmã®ç®èæ ãå¯Ÿç §è
è ¹åºåããïŒæãåŠçœ®èè ¹åºåããïŒæãããã
ææãããããªããŠãŒã æšèä»ããããžã³ïŒ10ã
ã€ã¯ãããŠãªãŒïŒmlïŒãå«æãããã«ããã³
ïŒDulbeccoïŒã®å€æ§ã€ãŒã°ã«ã¡ãžãŠãŒã ïŒmlã«äž
èšç®èæ ãããããæµ®ãããŠ37ãã§å¹é€ãããïŒ
æéå¹é€ããåŸãç®èæ ãåçµãã解ãããåžå
çŽã§ä¹Ÿç¥ãã30ïŒ é ¢é žæ°Žæº¶æ¶²ã§ïŒåç¡æ°Žãšã¿ããŒ
ã«äžã§ïŒå泚ããæªçµåããªããŠãŒã æšèä»ãã
ããžã³ãé€å»ãããæŽæµããç®èæ ãNCSå¯æº¶
åå€äžã§æž©æµžããŠãDNAäžã«ç·šå ¥çµåããããª
ããŠãŒã æšèä»ããããžã³ã®éã枬å®ããçºã®ã·
ã³ãã¬ãŒã·ãšã³èšæ°æº¶æ¶²äœãšãããåŠçœ®ã«ããæ
å¶å¹æã¯ãåŠçœ®åºåããæ¡åããç®èæ äžã«ç·šå ¥
çµåãããæŸå°èœã®éãšå¯Ÿç §èè ¹åºåããæ¡åã
ãç®èæ äžãžç·šå ¥çµåããæŸå°èœã®éãæ¯èŒãã
ããšã«ãã枬å®ãããããããã®è©Šéšã«å°ããšã
ïŒå¹ã®åç©ãçšãããããŒã¿ã¯ããããã®åç©ã«
ã€ããŠãåŠçåºåã«æŒããå¹³åæŸå°èœãšå¯Ÿç §åºå
ã«æŒããå¹³åæŸå°èœãšã®æ¯ïŒÃ100ïŒãšããŠèšé²
ããã
çµåããããªããŠãŒã æšèä»ããããžã³ã®éã¯
åºæ¬çã«ã¯è¡šç®çŽ°èã«äŸåããæ ããããã®è©Šéš
ã«æŒããæŸå°èœã®éã¯èŽæ»æç¹ã«æŒããŠå¢æ®
ïŒDNAåæïŒã«é¢äžãã现èïŒè¡šç®ïŒã®æ°ã«çŽæ¥
é¢é£ãããåã«è¿°ã¹ãããã«ãè¡šç®çŽ°èéå¢æ®ã¯
也ç¬ã®çç¶ã§ãããæ¬çºæã«ä¿ãååç©ã¯è¡šç®çŽ°
èå¢æ®ã«å¯Ÿãæå¶æŽ»æ§ã瀺ãããåŸã€ãŠæ也ç¬å€
ã§ããã
åºæ¬çã«ã¯è¡šç®çŽ°èã«äŸåããæ ããããã®è©Šéš
ã«æŒããæŸå°èœã®éã¯èŽæ»æç¹ã«æŒããŠå¢æ®
ïŒDNAåæïŒã«é¢äžãã现èïŒè¡šç®ïŒã®æ°ã«çŽæ¥
é¢é£ãããåã«è¿°ã¹ãããã«ãè¡šç®çŽ°èéå¢æ®ã¯
也ç¬ã®çç¶ã§ãããæ¬çºæã«ä¿ãååç©ã¯è¡šç®çŽ°
èå¢æ®ã«å¯Ÿãæå¶æŽ»æ§ã瀺ãããåŸã€ãŠæ也ç¬å€
ã§ããã
æ¿åºŠïŒ
溶å€ïŒæ¯ïŒ æå¹åºŠ*
ïŒïŒ
DMSOïŒEtOHïŒïŒïŒïŒïŒ 69.56
ïŒïŒ
DMSOïŒEtOHïŒã¢ã»ãã³ïŒïŒïŒ4.5ïŒ
4.5ïŒ 85.82 ïŒ åŠçåºåå¹³åæŸå°èœïŒå¯Ÿç §åºåå¹³åæŸå°
èœÃ100 å®æœäŸ ïŒ äœéçŽ25ïœã®ã¹ã€ã¹ãŠãšãã¹ã¿ãŒããŠã¹ïŒã·ã¢
ã³ã»ã³ïŒ24å¹ãïŒå¹ãã€ïŒã€ã®åºåã«åãããïŒ
矀äžïŒã€ã®çŸ€ã®ããŠã¹ã«ïŒâã¯ããâïŒã»ïŒâãž
ããããã·âïŒã»ïŒâãããããã³ã®ã«ã«ãã¡ã
ãã·ã»ã«ããŒãºæº¶æ¶²ãç®äžæ³šå°ãããïŒã€ã®çŸ€ã«
察ããæäžéã¯10mgïŒKgã50mgïŒKgåã³250mgïŒ
Kgã§ãã€ãããã®æäžéã¯ããŠã¹äžå¹åœãããã
ããçŽ0.25mgã1.250mgåã³6.25mgã«çžåœããã察
ç §åºåã®ããŠã¹ã«ã¯ã«ã«ãã¡ããã·ã»ã«ããŒãºã
ç®äžæ³šå°ãããè©Šéšç©è³ªã¯ïŒæ¥ã®ã¿æäžããããŠ
ã¹ã®æ»äº¡çã14æ¥éã«äºã€ãŠæ¯æ¥èŠ³å¯ããããã
ãã®çŸ€ã«ãæ»äº¡ã¯èªããããªãã€ããåŸã€ãŠ
LD50ã¯250mgïŒKgãã倧ããã€ãã
4.5ïŒ 85.82 ïŒ åŠçåºåå¹³åæŸå°èœïŒå¯Ÿç §åºåå¹³åæŸå°
èœÃ100 å®æœäŸ ïŒ äœéçŽ25ïœã®ã¹ã€ã¹ãŠãšãã¹ã¿ãŒããŠã¹ïŒã·ã¢
ã³ã»ã³ïŒ24å¹ãïŒå¹ãã€ïŒã€ã®åºåã«åãããïŒ
矀äžïŒã€ã®çŸ€ã®ããŠã¹ã«ïŒâã¯ããâïŒã»ïŒâãž
ããããã·âïŒã»ïŒâãããããã³ã®ã«ã«ãã¡ã
ãã·ã»ã«ããŒãºæº¶æ¶²ãç®äžæ³šå°ãããïŒã€ã®çŸ€ã«
察ããæäžéã¯10mgïŒKgã50mgïŒKgåã³250mgïŒ
Kgã§ãã€ãããã®æäžéã¯ããŠã¹äžå¹åœãããã
ããçŽ0.25mgã1.250mgåã³6.25mgã«çžåœããã察
ç §åºåã®ããŠã¹ã«ã¯ã«ã«ãã¡ããã·ã»ã«ããŒãºã
ç®äžæ³šå°ãããè©Šéšç©è³ªã¯ïŒæ¥ã®ã¿æäžããããŠ
ã¹ã®æ»äº¡çã14æ¥éã«äºã€ãŠæ¯æ¥èŠ³å¯ããããã
ãã®çŸ€ã«ãæ»äº¡ã¯èªããããªãã€ããåŸã€ãŠ
LD50ã¯250mgïŒKgãã倧ããã€ãã
å®æœäŸ ïŒ
ïŒâã¯ããâïŒâããããã·âïŒã»ïŒâããã
ããã³ïŒãŸãã¯ïŒâã¯ãããŸãã¯ãã®æ··åç©ïŒ
1.2ã°ã©ã åã³éçé žãããªãŠã 0.48ïœã®æ°ŽïŒ58
mlïŒæº¶æ¶²ãïŒâã«å·åŽãã30ïŒ éé žåæ°ŽçŽ 2.3ml
ãïŒåºŠã«å ããã次ãã§æ··åç©ã22âã«æŒããŠ16
æéæ¹æããåŸãããèµ€è²çµæ¶æ§çæç©ïŒ0.24
ïœïŒãå¥ããæ°ŽïŒã¡ã¿ããŒã«ïŒïŒïŒïŒïŒããçµ
æ¶åããŠïŒâã¯ããâïŒã»ïŒâãžããããã·â
ïŒã»ïŒâãããããã³ãåŸããm.p.228â229â å®æœäŸ ïŒ ïŒâã¯ããâïŒã»ïŒâãžããããã·âïŒã»ïŒâ
ãããããã³ïŒïœã®ç¡æ°Žé ¢é žïŒmläžæžæ¿æ¶²ã«æ¿ç¡«
é žïŒ0.1mlïŒãå ããæ··åç©ãéæãªæ·¡é»è²æº¶æ¶²
ãšãªããŸã§ïŒïŒåé以å ïŒ22âã«æŒããŠãããã
ã«ããæ··ãããããã«22âã«ïŒåéä¿æããåŸã
溶液ã飜åéçé žãããªãŠã 溶液250mläžã«æ³š
ããé»è²çµæ¶æ§ç©è³ªãéããŠéããæ°Žã§ããæŽ
æµããæžå§ä¹Ÿç¥ããŠïŒã»ïŒâãžã¢ã»ããã·âïŒâ
ã¯ããâïŒã»ïŒâãããããã³1.05ïœãåŸããm.
p.109â110âã
ããã³ïŒãŸãã¯ïŒâã¯ãããŸãã¯ãã®æ··åç©ïŒ
1.2ã°ã©ã åã³éçé žãããªãŠã 0.48ïœã®æ°ŽïŒ58
mlïŒæº¶æ¶²ãïŒâã«å·åŽãã30ïŒ éé žåæ°ŽçŽ 2.3ml
ãïŒåºŠã«å ããã次ãã§æ··åç©ã22âã«æŒããŠ16
æéæ¹æããåŸãããèµ€è²çµæ¶æ§çæç©ïŒ0.24
ïœïŒãå¥ããæ°ŽïŒã¡ã¿ããŒã«ïŒïŒïŒïŒïŒããçµ
æ¶åããŠïŒâã¯ããâïŒã»ïŒâãžããããã·â
ïŒã»ïŒâãããããã³ãåŸããm.p.228â229â å®æœäŸ ïŒ ïŒâã¯ããâïŒã»ïŒâãžããããã·âïŒã»ïŒâ
ãããããã³ïŒïœã®ç¡æ°Žé ¢é žïŒmläžæžæ¿æ¶²ã«æ¿ç¡«
é žïŒ0.1mlïŒãå ããæ··åç©ãéæãªæ·¡é»è²æº¶æ¶²
ãšãªããŸã§ïŒïŒåé以å ïŒ22âã«æŒããŠãããã
ã«ããæ··ãããããã«22âã«ïŒåéä¿æããåŸã
溶液ã飜åéçé žãããªãŠã 溶液250mläžã«æ³š
ããé»è²çµæ¶æ§ç©è³ªãéããŠéããæ°Žã§ããæŽ
æµããæžå§ä¹Ÿç¥ããŠïŒã»ïŒâãžã¢ã»ããã·âïŒâ
ã¯ããâïŒã»ïŒâãããããã³1.05ïœãåŸããm.
p.109â110âã
å®æœäŸ ïŒ
ïŒâã¯ããâïŒã»ïŒâãžããããã·âïŒã»ïŒâ
ãããããã³ïŒïœã®ã«ããã³é žç¡æ°Žç©ïŒmläžæžæ¿
液ã«æ¿ç¡«é žïŒ0.1mlïŒãå ããæ··åç©ãéæãªæ·¡
é»è²æº¶æ¶²ãåŸããããŸã§ïŒïŒåé以å ïŒ22âã«æŒ
ããŠããããã«ããæ··ãããããã«10åé22âã«
ä¿æããåŸæº¶æ¶²ã飜åéçé žãããªãŠã 溶液250
mläžã«æ³šãããææ©å±€ãé ¢é žãšãã«ã§æœåºãã次
ãã§é ¢é žãšãã«ãèžçºãããããåŸãããçæç©
ïŒïŒã»ïŒâãžã«ãããã·âïŒâã¯ããâïŒã»ïŒâ
ãããããã³ïŒãã溶é¢æ¶²ãšããŠãããµã³ïŒéšå
ã³ãšãŒãã«ïŒéšïŒæº¶éïŒæº¶éïŒãããªãæ··åç©ã
çšããŠèå±€ã¯ãããã°ã©ãã€ãŒã«ãã粟補ããã
RFå€ã¯0.62ã§ãã€ãã
ãããããã³ïŒïœã®ã«ããã³é žç¡æ°Žç©ïŒmläžæžæ¿
液ã«æ¿ç¡«é žïŒ0.1mlïŒãå ããæ··åç©ãéæãªæ·¡
é»è²æº¶æ¶²ãåŸããããŸã§ïŒïŒåé以å ïŒ22âã«æŒ
ããŠããããã«ããæ··ãããããã«10åé22âã«
ä¿æããåŸæº¶æ¶²ã飜åéçé žãããªãŠã 溶液250
mläžã«æ³šãããææ©å±€ãé ¢é žãšãã«ã§æœåºãã次
ãã§é ¢é žãšãã«ãèžçºãããããåŸãããçæç©
ïŒïŒã»ïŒâãžã«ãããã·âïŒâã¯ããâïŒã»ïŒâ
ãããããã³ïŒãã溶é¢æ¶²ãšããŠãããµã³ïŒéšå
ã³ãšãŒãã«ïŒéšïŒæº¶éïŒæº¶éïŒãããªãæ··åç©ã
çšããŠèå±€ã¯ãããã°ã©ãã€ãŒã«ãã粟補ããã
RFå€ã¯0.62ã§ãã€ãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ æ¬¡ã®äžè¬åŒã§è¡šããããååç©ã äžèšåŒã«æŒããŠãã¯æ°ŽçŽ ãŸãã¯R1CïŒïŒ¯ïŒâ
ïŒR1ã¯ïŒä¹è³ïŒåã®ççŽ ååãæããã¢ã«ãã«ã§
ããïŒã§ããã ïŒ æ¬¡ã®äžè¬åŒã§è¡šããããååç©ã®æ²»ççæå¹
éã«å»è¬çã«èš±å®¹ããåŸãéæ¯æ§æ äœãçµã¿åã
ããŠãªãæ也ç¬å€çµæç©ã äžèšåŒã«æŒããŠãã¯æ°ŽçŽ ãŸãã¯R1CïŒïŒ¯ïŒâ
ïŒR1ã¯ïŒä¹è³ïŒåã®ççŽ ååãæããã¢ã«ãã«ã§
ããïŒã§ããã ïŒ æ¬¡ã®äžè¬åŒã§è¡šããããååç©ã®æ²»ççæå¹
éãåºä¹³åç©ïŒãããé€ãïŒã«å±ææäžããããš
ãããªãåºä¹³åç©ïŒãããé€ãïŒã®ä¹Ÿç¬ç¶æ ã解
æŸããæ¹æ³ã äžèšåŒã«æŒããŠãã¯æ°ŽçŽ ãŸãã¯R1CïŒïŒ¯ïŒâ
ïŒR1ã¯ïŒä¹è³ïŒåã®ççŽ ååãæããã¢ã«ãã«ã§
ããïŒã§ããã ïŒ ïŒâã¯ããâïŒã»ïŒâãã¿ã«ã¢ã«ããããšã°
ãªãªããµãŒã«ãšãæ¥è§Šåå¿ãããããšãããªã次
ã®ååŠåŒã§è¡šããããååç©ã調補ããæ¹æ³ã ïŒ ïŒâã¯ããâïŒâããããã·âïŒã»ïŒâãã
ãããã³ãïŒâã¯ããâïŒâããããã·âïŒã»ïŒ
âãããããã³ãŸãã¯ãã®æ··åç©ãïŒâä¹è³åå¿
åªäœã®æ²žç¹ã«æŒããŠé žåããããšãããªã次ã®å
åŠåŒã§è¡šããããååç©ã調補ããæ¹æ³ã ïŒ æ¬¡ã®ååŠåŒ ã§è¡šããããååç©ãâ10âä¹è³50âã«æŒããŠãž
ãšã¹ãã«åããããšãããªã次ã®äžè¬åŒã§è¡šãã
ããååç©ã調補ããæ¹æ³ã äžåŒã«æŒããŠR1ã¯ïŒä¹è³ïŒåã®ççŽ ååãæ
ããã¢ã«ãã«ã§ããã
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/912,697 US4229478A (en) | 1978-06-05 | 1978-06-05 | Naphthaquinone anti-psoriatic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5511573A JPS5511573A (en) | 1980-01-26 |
JPS6256851B2 true JPS6256851B2 (ja) | 1987-11-27 |
Family
ID=25432288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6954579A Granted JPS5511573A (en) | 1978-06-05 | 1979-06-05 | Novel naphthoquinones*their manufacture and medical composition containing them |
Country Status (6)
Country | Link |
---|---|
US (1) | US4229478A (ja) |
EP (1) | EP0007985B1 (ja) |
JP (1) | JPS5511573A (ja) |
AT (1) | ATE1500T1 (ja) |
DE (1) | DE2963603D1 (ja) |
ES (1) | ES481235A1 (ja) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4442127A (en) * | 1978-06-05 | 1984-04-10 | Syntex (U.S.A.) Inc. | Naphthoquinone anti-psoriatic agents |
US4419368A (en) * | 1978-06-05 | 1983-12-06 | Syntex (U.S.A.) Inc. | Naphthoquinone anti-psoriatic agents |
US4466981A (en) * | 1982-10-27 | 1984-08-21 | Syntex (U.S.A.) Inc. | Naphthalene anti-psoriatic agents |
DE3347658A1 (de) * | 1983-12-31 | 1985-07-11 | Troponwerke GmbH & Co KG, 5000 Köln | 1.4-naphthochinonderivate mit entzuendungshemmender wirkung |
HU194533B (en) * | 1984-01-27 | 1988-02-29 | Syntex Inc | Process for preparing naphthalene derivatives and pharmaceutical compositions containing such compounds as active substances |
US4562004A (en) * | 1984-03-14 | 1985-12-31 | Basf Aktiengesellschaft | 2,3,5,6-Tetrasubstituted p-benzoquinones and their preparation |
DE3431236A1 (de) * | 1984-08-24 | 1986-02-27 | Carnivora-Deutschland GmbH, 7109 Jagsthausen | Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation |
US4592867A (en) * | 1984-10-19 | 1986-06-03 | Energy Conversion Devices, Inc. | Synthesis method for reductant precursor |
US4786652A (en) * | 1987-03-09 | 1988-11-22 | Syntex (U.S.A.) Inc. | Naphthalene anti-psoriatic agents |
US5134161A (en) * | 1987-03-09 | 1992-07-28 | Syntex (U.S.A.) Inc. | Method for treating disease states in mammals with naphthalene lipoxygenase-inhibiting agents |
JPS63250338A (ja) * | 1987-03-09 | 1988-10-18 | ã·ã³ããã¯ã¹ïŒãŠãŒããšã¹ããšã€ïŒãã€ã³ã³ãŒãã¬ãŒããã | æ也ç¬æ§ããã¿ã¬ã³ååç© |
US4840965A (en) * | 1987-07-07 | 1989-06-20 | Syntex (U.S.A.) Inc. | Naphthalene anti-psoriatic agents |
US5849793A (en) * | 1997-08-15 | 1998-12-15 | The Picower Institute For Medical Research | HIV matrix protein tyrosine position 29 pocket binders |
BE1012264A3 (fr) * | 1998-11-05 | 2000-08-01 | Solvay | Nouvelles naphtalenediones et leur utilisation dans la preparation d' anthracenediones. |
US6884797B2 (en) * | 2001-03-30 | 2005-04-26 | Robert F. Hofmann | Targeted oxidative therapeutic formulation |
WO2010005989A1 (en) * | 2008-07-09 | 2010-01-14 | Edison Pharmaceuticals, Inc. | Dermatological compositions with anti-aging and skin even-toning properties |
US20100029784A1 (en) * | 2008-07-30 | 2010-02-04 | Hinman Andrew W | Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning properties |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3914264A (en) * | 1975-01-30 | 1975-10-21 | American Cyanamid Co | 2-Lower alkoxy-3-(lower alkylthio)-1,4-naphthoquinone |
-
1978
- 1978-06-05 US US05/912,697 patent/US4229478A/en not_active Expired - Lifetime
-
1979
- 1979-06-04 ES ES481235A patent/ES481235A1/es not_active Expired
- 1979-06-05 EP EP79101778A patent/EP0007985B1/en not_active Expired
- 1979-06-05 JP JP6954579A patent/JPS5511573A/ja active Granted
- 1979-06-05 DE DE7979101778T patent/DE2963603D1/de not_active Expired
- 1979-06-05 AT AT79101778T patent/ATE1500T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES481235A1 (es) | 1980-02-16 |
JPS5511573A (en) | 1980-01-26 |
EP0007985A1 (en) | 1980-02-20 |
ATE1500T1 (de) | 1982-09-15 |
DE2963603D1 (en) | 1982-10-28 |
EP0007985B1 (en) | 1982-09-01 |
US4229478A (en) | 1980-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6256851B2 (ja) | ||
US4225619A (en) | Substituted fluoracylresorcinols | |
KR880002309B1 (ko) | ëííë ì ë첎ì ì ì¡°ë°©ë² | |
FR2638161A1 (fr) | Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant | |
US3716531A (en) | 5-nitro-furfurylidene antimicrobic agents | |
EP0150831B1 (en) | Naphthalene anti-psoriatic agents | |
US3182061A (en) | 5-[4-(p-hydroxyphenoxy)phenyl]-5-oxo-3-methylvaleric acid | |
US4255405A (en) | Naphthoquinone anti-psoriatic agents | |
US3210413A (en) | Antihypercholesterolemic agents | |
US4569945A (en) | Diarylindane-1,3-diones, their preparation and use | |
US3354201A (en) | p-dihydroxybenzene-sulfonate of diethylamine | |
US4786652A (en) | Naphthalene anti-psoriatic agents | |
US4442127A (en) | Naphthoquinone anti-psoriatic agents | |
US3201475A (en) | Bisglyoxalyldiphenyl derivatives | |
GB2094297A (en) | Apovincaminol derivatives | |
EP0215622B1 (en) | Naphthalene anti-psoriatic agents and process for making them | |
EP0147174B1 (en) | Dihydroxybenzaldehyde derivatives as anti-inflammatory agents | |
US5134161A (en) | Method for treating disease states in mammals with naphthalene lipoxygenase-inhibiting agents | |
AU617663B2 (en) | Naphthalene anti-psoriatic agents | |
US3391163A (en) | 10, 5-(epoxymethano)-10, 11-dihydro-5h-dibenzo [a, d] cycloheptene-11, 13-dione | |
US4218473A (en) | Derivatives of 4-cyclohexyl-1-naphthalene-acetic acid and their use as drugs | |
US5091558A (en) | Naphthalene anti-psoriatic agents | |
US5155132A (en) | Naphthalene lipoxygenase-inhibiting agents | |
EP0282006A1 (en) | Naphtalene anti-psoriatic agents | |
FR2692894A1 (fr) | Aryl-1-(o-alcoxy-phényl-4-pipérazinyl-1)-2, 3- ou 4-alcanols, leur procédé de préparation et leur utilisation pour la préparation de médicaments. |